TITAN PHARMACEUTICALS INC (TTNP)
US8883147055 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -5.57M | -10.21M | -8.78M | -18.24M | -16.46M | |||
| Depreciation Amortization | 112.00K | 200.00K | 220.00K | 290.00K | 240.00K | |||
| Change In Working Capital | -916.00K | 380.00K | -220.00K | 1.02M | 960.00K | |||
| Interest Paid | 21.00K | N/A | 0.00 | 300.00K | 430.00K | |||
| Other non cash items | -719.00K | 1.45M | 880.00K | -270.00K | -190.00K | |||
| OPERATING CASH FLOW | -7.09M | -8.18M | -7.90M | -17.20M | -15.45M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.00K | 0.00 | -20.00K | -540.00K | -260.00K | |||
| Other Investing Activity | 734.00K | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | 732.00K | 0.00 | -20.00K | -540.00K | -260.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 500.00K | N/A | 0.00 | -950.00K | 0.00 | |||
| Stock Issued/Repurchased | 9.50M | 4.98M | 8.84M | 18.88M | 11.27M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 10.00M | 4.98M | 8.84M | 17.93M | 11.27M | |||
| CHANGE IN CASH | 3.64M | -3.20M | 920.00K | 190.00K | -4.44M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -7.09M | -8.18M | -7.90M | -17.20M | -15.45M | |||
| Capital Expenditure | -2.00K | 0.00 | -20.00K | -540.00K | -260.00K | |||
| FREE CASH FLOW | -7.09M | -8.18M | -7.92M | -17.74M | -15.71M | |||
All data in USD